ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2501

Mirorna Mir-150 Contributes to Chronic Kidney Injury in Lupus Nephritis by Increasing the Synthesis of Fibrotic Proteins Via Downregulation of SOCS1

Hua Zhou1, Sarfaraz A. Hasni2, Mayank Tandon3, Shyh-Ing Jang4, Howard A. Austin5, James E. Balow6, Ilias Alevizos3 and Gabor G. Illei3, 1NIDCR/NIH, Bethesda, MD, 2National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 3Sjogren's Clinic, NIDCR/NIH, Bethesda, MD, 4Molecular Physiology and Therapeutics Branch, NIDCR/NIH, Bethesda, MD, 5Kidney Disease Section, NIDDK/NIH, Bethesda, MD, 6Clinical Director, NIDDK, NIDDK/NIH, Bethesda, MD

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Collagen, epigenetics and lupus nephritis

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis II

Session Type: Abstract Submissions (ACR)

Background/Purpose: We have previously shown that renal expression of miR-150 correlates with chronicity index (CI) in lupus nephritis. Since fibrosis is a major histologic feature of the CI we explored the potential role of miR-150 in renal fibrosis. Our data showed a positive correlation between fibrosis and miR-150 expression, therefore we assumed that miR-150 increases the production of pro-fibrotic molecules by downregulating a regulator of fibrotic proteins. The European Bioinformatic Institute (EBI) database identified SOCS-1 (suppressor of cytokine signaling-1) as such a target of miR-150. SOCS-1 has previously been shown to decrease fibronectin in mesangial cells as well as reduce fibronectin and collagen 1 in renal tubular fibroblast. SOCS1-/- mice developed lupus nephritis-like disease. We hypothesized that miR-150 increases the synthesis of profibrotic molecules by down regulating SOCS1.

Methods: The localization of miR-150 in kidney was identified by in situ hybridization in 6 kidney needle biopsies from patients with lupus nephritis (3 from patients with high renal miR-150 and 3 from patients with low renal miR150) and 2 kidneys from autopsies without known kidney diseases. Renal collagen 1(COL1) immunofluorescent staining was performed on the same samples. Primary human renal proximal tubular epithelial cells (RPTEC) and primary human mesangial cells (MC) were used for transfection with miR-150. To confirm SOCS1 as a mir-150 target a luciferase gene linked with the 3’UTR of SOCS1 was cotransfected with miR-150 in RPTEC cells and the luciferase activity was measured 48hrs after the cotransfection. Protein expression of SOCS1 and fibrotic proteins,  COL1, collagen 3 (COL3) and fibronectin (FN) were analyzed by western blot in these cultured cells 48hr after miR-150 transfection.

Results: miR-150 predominantly localized in renal cortical proximal tubular cells. Moderate staining was seen in podocytes in kidney biopsies with high but not in those with low renal miR-150 expression. Immunofluorescent staining showed significantly increased COL1 in kidney biopsies with high renal miR-150 and high CI compared to the kidneys with low renal miR-150 and low CI. Luciferase activity linked to the 3’UTR of SOCS1 was downregulated to 68.5% (p<0.01) of control cells by miR-150 in RPTEC, confirming SOCS1 as a direct target of miR-150. miR-150 transfection significantly decreased SOCS1 signal and increased expression of FN in both RPTEC and MC whereas it led to increased levels of COL3 in RPTEC and COL1 levels in mesangial cells.       

Conclusion: miR-150 transfection increased the synthesis of pro-fibrotic molecules in two primary human renal cells by downregulating the expression of SOCS1, a negative regulator of fibrosis. These data together with the previously described obseravtion that miR-150 expression in lupus nephritis correlates with chronicity index suggest that miR-150 plays an important role in chronic kidney injury in lupus nephritis.


Disclosure:

H. Zhou,
None;

S. A. Hasni,
None;

M. Tandon,
None;

S. I. Jang,
None;

H. A. Austin,
None;

J. E. Balow,
None;

I. Alevizos,
None;

G. G. Illei,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mirorna-mir-150-contributes-to-chronic-kidney-injury-in-lupus-nephritis-by-increasing-the-synthesis-of-fibrotic-proteins-via-downregulation-of-socs1/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology